Ausgabe 6/2019
Inhalt (23 Artikel)
Alternative dosing regimens for atezolizumab: right dose, wrong frequency
Daniel A. Goldstein, Mark J. Ratain
Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs
Vinay Sharma, Sonu Kumar Gupta, Malkhey Verma
A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials
Derek Gordon, David E. Axelrod
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Floor J. E. Lubberman, Guillemette E. Benoist, Winald Gerritsen, David M. Burger, Niven Mehra, Paul Hamberg, Inge van Oort, Nielka P. van Erp
Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate
Meng Gao, Dongjian Zhang, Nan Yao, Qiaomei Jin, Cuihua Jiang, Jian Zhang, Feng Wang
Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy
Yanshuo Cao, Qing Chang, Wenjiang Zhang, Olga Ornatsky, David Hedley, Eric X. Chen
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
Thehang Luu, Paul Frankel, Jan H. Beumer, Dean Lim, Mihaela Cristea, Leonard J. Appleman, Heinz J. Lenz, David R. Gandara, Brian F. Kiesel, Richard L. Piekarz, Edward M. Newman
Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway
Yanshan Zhang, Weizuo Chen, Huijuan Wang, Tingting Pan, Yinguo Zhang, Chao Li
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy
Stefania Crucitta, Giuliana Restante, Marzia Del Re, Ilaria Bertolini, Eleonora Bona, Eleonora Rofi, Lorenzo Fontanelli, Giulia Gianfilippo, Stefano Fogli, Irene Stasi, Matteo Ghilli, Andrea Fontana, Romano Danesi
ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer
Takehiro Uemura, Tetsuya Oguri, Ken Maeno, Kazuki Sone, Akira Takeuchi, Satoshi Fukuda, Eiji Kunii, Osamu Takakuwa, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi
Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer
Yuliang Sun, Xiaoqian Lin, Jennifer Carlson Aske, Ping Ye, Casey Williams, Mark Abramovitz, Brian R. Leyland-Jones
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
Kari M. Morrissey, Mathilde Marchand, Hina Patel, Rong Zhang, Benjamin Wu, H. Phyllis Chan, Almut Mecke, Sandhya Girish, Jin Y. Jin, Helen R. Winter, René Bruno
JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer
Takayuki Yoshino, Masahito Kotaka, Katsunori Shinozaki, Tetsuo Touyama, Dai Manaka, Takanori Matsui, Kiyoshi Ishigure, Junichi Hasegawa, Keiji Inoue, Yoshinori Munemoto, Akinori Takagane, Hiroshi Ishikawa, Hideyuki Ishida, Yutaka Ogata, Koji Oba, Koichi Goto, Junichi Sakamoto, Yoshihiko Maehara, Atsushi Ohtsu
BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells
Wei Yang, Sihui Zhao, Bian Wu, Jianbiao Xu, Zaozao Wu, Jianhui Guo, Rong Zeng
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard J. Appleman, Jan H. Beumer, Yixing Jiang, Yan Lin, Fei Ding, Shannon Puhalla, Leigh Swartz, Taofeek K. Owonikoko, R. Donald Harvey, Ronald Stoller, Daniel P. Petro, Hussein A. Tawbi, Athanassios Argiris, Sandra Strychor, Marie Pouquet, Brian Kiesel, Alice P. Chen, David Gandara, Chandra P. Belani, Edward Chu, Suresh S. Ramalingam
NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells
Ling Liu, Jingjing Chen, Mengyao Cao, Jiangang Wang, Shuying Wang
Combined thermo-chemotherapy of cancer using 1 MHz ultrasound waves and a cisplatin-loaded sonosensitizing nanoplatform: an in vivo study
Rasoul Irajirad, Amirhossein Ahmadi, Bahareh Khalili Najafabad, Ziaeddin Abed, Roghayeh Sheervalilou, Samideh Khoei, M. Bagher Shiran, Habib Ghaznavi, Ali Shakeri-Zadeh
A phase I delayed-start, randomized and pharmacodynamic study of metformin and chemotherapy in patients with solid tumors
Mohammad Wasif Saif, Shrikar Rajagopal, Jennifer Caplain, Elizabeth Grimm, Oksana Serebrennikova, Madhumita Das, Philip N. Tsichlis, Robert Martell
Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1
Caner Turan, Mehmet Kantar, Çağdaş Aktan, Buket Kosova, Mehmet Orman, Cem Bilgen, Tayfun Kirazlı
Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients
Sonoko Kawakatsu, Mina Nikanjam, Mark Lin, Sonny Le, Ila Saunders, Dennis John Kuo, Edmund V. Capparelli
Metformin plus first-line chemotherapy versus chemotherapy alone in the treatment of epithelial ovarian cancer: a prospective open-label pilot trial
Ya Zheng, Jie Zhu, Haiyan Zhang, Yanmei Liu, Hong Sun
Prevalence of the DPYD variant (Y186C) in Brazilian individuals of African ancestry
Geraldo Felício Cunha-Junior, Luciana Bastos-Rodrigues, Pedro G. Azevedo, Maria Aparecida Bicalho, Luiz Alexandre V. Magno, Luiz De Marco, Luiz Gonzaga Coelho
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
Fernando Rivera, C. Romero, P. Jimenez-Fonseca, M. Izquierdo-Manuel, A. Salud, E. Martínez, M. Jorge, V. Arrazubi, J. C. Méndez, P. García-Alfonso, M. Reboredo, J. Barriuso, N. Muñoz-Unceta, R. Jimeno, C. López